Literature DB >> 20331946

The universal data collection surveillance system for rare bleeding disorders.

J Michael Soucie1, Sally McAlister, Ann McClellan, Meredith Oakley, Ying Su.   

Abstract

Since 1998, the CDC has coordinated a national public health surveillance project-the Universal Data Collection (UDC) program-on chronic, rare, inherited bleeding disorders. In this program, uniform data are gathered through a network of 130 hemophilia treatment centers (HTCs) throughout the U.S. and its territories. Initially, the program was designed to address two primary goals: (1) establishment of a blood-safety monitoring system among people with bleeding disorders, and (2) collection of a uniform set of clinical outcomes data that could be used to monitor trends in the prevalence of infectious diseases and joint complications among this population. To this end, the program has been acquiring useful longitudinal data to monitor complications of bleeding disorders. For example, with the establishment of range-of-motion measurements for joints as required data elements, a large database has been developed for studies examining risk factors for joint-disease progression. The UDC program data have been used to provide evidence for a national prevention campaign to promote the need for patients with hemophilia to establish or maintain a healthy weight to help prevent joint disease. Risk factors leading to complications such as joint infection have also been identified. The application of geographic information systems technology to UDC program data has helped identify needs for outreach and availability of blood products and sources of care. Future analyses of data collected on babies, women, and individuals with rarer bleeding disorders than hemophilia will provide further information, leading to improved public health prevention strategies. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20331946     DOI: 10.1016/j.amepre.2009.12.023

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  31 in total

1.  Public health surveillance and data collection: general principles and impact on hemophilia care.

Authors:  J Michael Soucie
Journal:  Hematology       Date:  2012-04       Impact factor: 2.269

2.  Risk factors associated with invasive orthopaedic interventions in males with haemophilia enrolled in the Universal Data Collection program from 2000 to 2010.

Authors:  P Tobase; H Lane; A-E-A Siddiqi; J M Soucie; R Ingram-Rich; S Ward; J C Gill
Journal:  Haemophilia       Date:  2018-06-29       Impact factor: 4.287

3.  Prophylaxis use among males with haemophilia B in the United States.

Authors:  M Ullman; Q C Zhang; S D Grosse; M Recht; J M Soucie
Journal:  Haemophilia       Date:  2017-08-06       Impact factor: 4.287

4.  Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project.

Authors:  Marilyn J Manco-Johnson; J Michael Soucie; Joan Cox Gill
Journal:  Blood       Date:  2017-02-09       Impact factor: 22.113

5.  Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data.

Authors:  A Iorio; J S Stonebraker; M Brooker; J M Soucie
Journal:  Haemophilia       Date:  2016-12-08       Impact factor: 4.287

Review 6.  The national haemophilia program standards, evaluation and oversight systems in the United States of America.

Authors:  Mark W Skinner; J Michael Soucie; Kathryn Mclaughlin
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

7.  National surveillance for hemophilia inhibitors in the United States: Summary report of an expert meeting.

Authors:  J Michael Soucie; Connie H Miller; Fiona M Kelly; Diane Aschman; Donna DiMichele; Barbara A Konkle; Roshni Kulkarni; Paul E Monahan
Journal:  Am J Hematol       Date:  2014-04-10       Impact factor: 10.047

8.  Men with severe hemophilia in the United States: birth cohort analysis of a large national database.

Authors:  Marshall A Mazepa; Paul E Monahan; Judith R Baker; Brenda K Riske; J Michael Soucie
Journal:  Blood       Date:  2016-03-16       Impact factor: 22.113

9.  Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database.

Authors:  D Kelly; Q C Zhang; J M Soucie; M Manco-Johnson; D Dimichele
Journal:  Haemophilia       Date:  2012-12-17       Impact factor: 4.287

10.  The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.

Authors:  J Michael Soucie; Paul E Monahan; Roshni Kulkarni; Barbara A Konkle; Marshall A Mazepa
Journal:  Blood Adv       Date:  2018-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.